Neonatal Fever 0 to 28 Days - Sepsis Evaluation and Management

Key Points

• Fever is defined as a reliable temperature of at least 38.0°C.
• The AAP well-appearing febrile-infant guideline starts at 8 days, not birth.
• Infants 0 to 7 days old should be managed as high-risk neonates rather than placed into the AAP 8 to 60 day pathway.
• Young febrile infants need blood and catheterized urine testing and usually CSF evaluation according to age and appearance.
• Do not delay empiric antibiotics in an unstable infant to complete lumbar puncture.
• Neonatal HSV can occur without vesicles.
• HSV risk clues include maternal infection, vesicles, seizures, hepatitis, thrombocytopenia, hypothermia, and CSF pleocytosis.
• Start IV acyclovir promptly when neonatal HSV is reasonably suspected.
• Prematurity and medical complexity generally exclude infants from standard low-risk algorithms.
• Reliable follow-up is part of any decision to use less intensive management in the older portion of this age group.

Algorithm

1. Confirm fever of at least 38.0°C and assess appearance, airway, breathing, circulation, glucose, and perfusion.
2. Obtain pregnancy, delivery, maternal infection, gestational-age, and neonatal history.
3. Obtain blood culture and catheterized urine for urinalysis and culture.
4. For 0 to 21 days, pursue CSF evaluation and hospital-based empiric therapy unless instability requires treatment before LP.
5. For 22 to 28 days, apply age-specific inflammatory-marker and CSF pathway while maintaining a low threshold for admission and parenteral therapy.
6. Assess HSV risk from maternal history, vesicles, seizures, hepatitis, thrombocytopenia, CSF findings, or unexplained severe illness.
7. If HSV is suspected, obtain HSV studies and begin IV acyclovir promptly.
8. Give age-appropriate empiric parenteral antibacterial therapy.
9. Reassess cultures, PCR results, inflammatory markers, and clinical course to narrow therapy and determine disposition.

Clinical Synopsis & Reasoning

Any documented rectal temperature of at least 38.0°C in a young infant deserves urgent assessment. Neonates can deteriorate rapidly and may have bacteremia, urinary tract infection, meningitis, HSV infection, or another serious process despite initially normal appearance. Hypothermia can also be a sign of serious neonatal infection and should be evaluated in context.

Age matters. The 2021 AAP clinical practice guideline addresses well-appearing, term infants 8 to 60 days old and separates 8 to 21, 22 to 28, and 29 to 60 day groups. It does not apply to infants 0 to 7 days old. The first week of life is generally managed more conservatively as neonatal sepsis because maternal, perinatal, and early-onset pathogens remain important and the threshold for full evaluation and treatment is low.

Assess appearance, tone, perfusion, work of breathing, feeding, hydration, rash or vesicles, fontanelle, and focal findings. Obtain detailed birth history including gestational age, prolonged rupture of membranes, maternal fever, group B streptococcal status and prophylaxis, maternal HSV lesions or history, intrapartum antibiotics, neonatal ICU course, and prior antibiotics. Prematurity or significant medical complexity places the infant outside many low-risk pathways.

HSV deserves active consideration because delayed acyclovir in disseminated or CNS disease can be catastrophic. Clues include maternal genital lesions or primary infection near delivery, vesicular rash, seizures, ill appearance, hypothermia, hepatitis or elevated transaminases, thrombocytopenia, CSF pleocytosis, or unexplained severe illness. Absence of vesicles does not exclude neonatal HSV.

Treatment Strategy & Disposition

Stabilize airway, breathing, circulation, glucose, and perfusion first in an ill infant. Obtain blood culture, catheterized or suprapubic urine for urinalysis and culture, and CSF for cell count, glucose, protein, Gram stain, bacterial culture, and other testing dictated by the clinical scenario. Do not delay antibiotics for a lumbar puncture if the infant is unstable or the procedure cannot be performed promptly.

For infants in the first week of life and generally for febrile infants 8 to 21 days old, hospital management with parenteral empiric antibiotics and CSF evaluation is standard. Common empiric regimens include ampicillin plus gentamicin for neonatal sepsis coverage, with a third-generation cephalosporin selected according to age, meningitis concern, and institutional neonatal practice. Ceftriaxone has special limitations in young neonates, particularly with hyperbilirubinemia and calcium-containing IV solutions, so local neonatal protocols matter.

Infants 22 to 28 days remain high risk. The AAP pathway uses urinalysis, blood culture, inflammatory markers, and selective CSF decision-making based on results and shared decision frameworks, but many clinicians maintain a low threshold for lumbar puncture, parenteral antibiotics, and admission. Ill-appearing infants are not candidates for a low-risk outpatient pathway.

When neonatal HSV is suspected, obtain surface or mucosal HSV PCR/cultures according to local protocol, blood HSV PCR, liver transaminases, and CSF HSV PCR when safe, and start IV acyclovir without waiting for results. Acyclovir dosing for neonatal HSV is commonly 20 mg/kg IV every 8 hours, with duration determined by disease classification and virologic response. Provide IV fluids and monitor renal function because acyclovir can crystallize in renal tubules, particularly with dehydration.

Admit infants requiring empiric therapy or whose age, results, appearance, or follow-up reliability creates significant risk. Narrow or stop therapy when cultures, HSV testing, clinical course, and age-specific criteria support doing so.

Epidemiology / Risk Factors

• Urinary tract infection is among the most common bacterial infections in febrile young infants.
• Bacteremia and bacterial meningitis are less common but carry high morbidity and justify conservative management in the youngest infants.
• HSV is uncommon but has high consequence when diagnosis and therapy are delayed.
• Risk of invasive bacterial infection declines with age across the first two months but is highest in the neonatal period.

Investigations

HSV Risk Clues

Pharmacology

Prognosis / Complications

• Most febrile infants do not have bacterial meningitis, but early identification of the minority with invasive disease is critical.
• Prompt antibacterial treatment generally produces good outcomes for susceptible bacterial infection.
• Neonatal HSV prognosis is substantially better when acyclovir is started before advanced disseminated or CNS injury.
• Delayed recognition of sepsis, meningitis, or HSV can lead to neurologic injury, shock, or death.
• Age-specific evaluation allows older well-appearing infants to avoid some unnecessary invasive testing while preserving safety.

Patient Education / Counseling

• Tell caregivers that fever in the first month requires urgent medical evaluation even when the infant looks well.
• Teach caregivers not to give leftover antibiotics before evaluation because this can obscure cultures.
• Explain why urine must be collected by catheter rather than a bag when culture accuracy matters.
• Review signs requiring immediate escalation: poor feeding, lethargy, breathing difficulty, color change, seizures, new vesicles, or reduced urine output.
• Discuss the reason for hospitalization and culture observation when the infant requires empiric treatment.
• Provide explicit follow-up instructions if an older infant in this age band qualifies for any outpatient component of care.

Notes

The title spans 0 to 28 days, but that period is not one homogeneous guideline group. The AAP febrile-infant guideline begins at 8 days and separates 8 to 21 and 22 to 28 day management. Infants younger than 8 days require neonatal sepsis reasoning outside that guideline.

HSV is the major high-consequence diagnosis that can be missed when a febrile neonate is treated as a routine bacterial sepsis case. Institutions should have an explicit HSV testing and acyclovir pathway so treatment does not depend on whether a clinician remembers every risk factor during a busy emergency evaluation.

References

1. AAP Clinical Practice Guideline: Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old — Link
2. AAP News Summary of Febrile Infant Clinical Practice Guideline — Link